Rebuelto Marcela, Loza María Elena
Farmacología, Facultad de Ciencias Veterinarias, Universidad de Buenos Aires, Chorroarín 280, 1427 Buenos Aires, Argentina.
Vet Med Int. 2010 Dec 14;2010:385640. doi: 10.4061/2010/385640.
The use of pharmacological agents in pregnant females poses a major clinical challenge due to the marked physiological changes that may modify the pharmacokinetics of drugs and to the potential effects on the fetus. The purpose of this paper is to review briefly our knowledge on the use of antibacterial drugs during pregnancy and to provide information for the judicious selection of an antimicrobial treatment for use in pregnant bitches and queens. The risk to the fetus is a result of the ability of a drug to reach the fetal circulation and to produce toxic effects. The placenta functions as a barrier that protects the fetus due to the presence of transporters and metabolising enzymes; however, during pregnancy, the presence and activity of both enzymes and transporters may change. Antimicrobial agents that have been shown to be safe for use during pregnancy include betalactams, macrolides, and lincosamides. Pharmacotherapy during pregnancy in all species may affect adversely the developing fetus; therefore, it should be avoided when possible.
由于怀孕女性会发生显著的生理变化,这些变化可能会改变药物的药代动力学,并且药物对胎儿可能产生潜在影响,因此在怀孕女性中使用药物制剂带来了重大的临床挑战。本文的目的是简要回顾我们关于孕期使用抗菌药物的知识,并为明智选择用于怀孕母犬和母猫的抗菌治疗提供信息。药物对胎儿的风险源于药物进入胎儿循环并产生毒性作用的能力。胎盘由于存在转运体和代谢酶而起到保护胎儿的屏障作用;然而,在怀孕期间,酶和转运体的存在及活性可能会发生变化。已证明在孕期使用安全的抗菌药物包括β-内酰胺类、大环内酯类和林可酰胺类。所有物种在孕期进行药物治疗都可能对发育中的胎儿产生不利影响;因此,应尽可能避免。